131 related articles for article (PubMed ID: 10855011)
21. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
22. The in-vitro activity of colistin in gram-negative bacteria.
Tan TY; Ng SY
Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
Castanheira M; Jones RN; Livermore DM
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):426-33. PubMed ID: 19249180
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
[TBL] [Abstract][Full Text] [Related]
26. Comparative bactericidal and morphological effects of five cephamycins on cells of three gram-negative bacilli at decreasing drug concentrations.
Goi H; Watanabe T; Miyauchi K; Kazuno Y; Inouye S
Drugs Exp Clin Res; 1985; 11(11):771-80. PubMed ID: 3915467
[TBL] [Abstract][Full Text] [Related]
27. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Gales AC; Jones RN; Sader HS
Clin Microbiol Infect; 2006 Apr; 12(4):315-21. PubMed ID: 16524407
[TBL] [Abstract][Full Text] [Related]
28. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
29. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
Orrett FA
Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
[TBL] [Abstract][Full Text] [Related]
30. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
31. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
[TBL] [Abstract][Full Text] [Related]
32. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.
Lewis RT; Duma RJ; Echols RM; Jemsek JG; Najem AZ; Press RA; Stone HH; Ton GT; Wilson SE
Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):728-35. PubMed ID: 3281463
[TBL] [Abstract][Full Text] [Related]
34. Newer antibiotics: their place in geriatric care. Part I.
Gleckman RA; Bergman MM
Geriatrics; 1986 Dec; 41(12):51-5. PubMed ID: 3465671
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
36. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of cefminox, a new bactericidal cephamycin.
Watanabe S; Omoto S
Drugs Exp Clin Res; 1990; 16(9):461-7. PubMed ID: 2100248
[TBL] [Abstract][Full Text] [Related]
38. [Anaerobic bacteria isolated from patients with suspected anaerobic infections].
Ercis S; Tunçkanat F; Hasçelik G
Mikrobiyol Bul; 2005 Oct; 39(4):447-54. PubMed ID: 16544546
[TBL] [Abstract][Full Text] [Related]
39. The challenge of multidrug resistance: the treatment of gram-negative rod infections.
Levin AS; Oliveira MS
Shock; 2008 Oct; 30 Suppl 1():30-3. PubMed ID: 18704012
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
Fritsche TR; Stilwell MG; Jones RN
Clin Microbiol Infect; 2005 Dec; 11(12):974-84. PubMed ID: 16307551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
